A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group Study S0202

BACKGROUND: Patients with gallbladder cancer or cholangiocarcinoma usually present with advanced disease and limited treatment options. Based on the common embryologic origin of the exocrine pancreas and gallbladder, coupled with data demonstrating effectiveness of gemcitabine in pancreatic carcinom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Iqbal, Syma, Rankin, Cathryn, Lenz, Heinz-Josef, Gold, Philip J., Ahmad, Syed A., El-Khoueiry, Anthony B., Messino, Michael J., Holcombe, Randall F., Blanke, Charles D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3519425/
https://ncbi.nlm.nih.gov/pubmed/21556747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-011-1657-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados